medigraphic.com
SPANISH

Revista del Hospital Juárez de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 4

<< Back Next >>

Rev Hosp Jua Mex 2014; 81 (4)

Participación de la proteína BIK en los procesos apoptóticos

Gutiérrez-Santana JC, García-Casillas G, Toscano-Garibay JD
Full text How to cite this article

Language: Spanish
References: 13
Page: 239-244
PDF size: 249.65 Kb.


Key words:

Apoptosis, BCL-2, BH domains, BH3-only, BIK.

ABSTRACT

Cell death (apoptosis) is a process relevant in the development and differentiation of multicellular organism and its alterations raise pathological conditions. Apoptosis is tightly regulated by a family known as BCL-2 proteins conformed by pro- and anti-apoptotic members that share structural domains (BH1-BH4). Some members of this family are exclusively activated in response to death signals with pro-apoptotic function and have homology barely at the BH3 domain (BH3-only proteins). BIK is a BH3-only protein embedded into the membrane of the endoplasmic reticulum inducing changes in Ca+2 levels consequently remodeling mitochondrial cristae and releasing cytochrome C as the initial step of apoptosis. Additionally, BIK cooperates with NOXA to activate BAX through a mitochondrial independent pathway. On the other hand, BIK expression is inducible by anti-estrogenic drugs and it has been related to p53 on MCF7 cells. Also, it has been observed that BIK is actively synthesized in breast cancer cells and is rapidly degraded in a proteasome-dependent manner with its levels being restored when proteasome inhibitors are used. Due to its role as apoptotic regulator BIK has become an important indirect therapeutic target, nonetheless being one of the less studied BH3-only members, its study would generate interesting biotechnological alternatives for a wide number of pathologies.


REFERENCES

  1. Cotter T. Apoptosis and cancer: the genesis of a research field. Nature Reviews Cancer 2009; 9: 501-7. Retrieved from http://dx.doi.org/10.1038/nrc2663.

  2. Han J, Sabbatini P, Sabbatini P, Perez D, Rao L, Mohda D, Grinham CJ. Induction of Apoptosis by Human Nbk / Bik , a BH3-Containing Protein That Interacts with E1B 19K. Molecular and cellular biology 1996; 16(10): 5857-64.

  3. Mathai JP, Germain M, Marcellus RC, Shore GC. Induction and endoplasmic reticulum location of BIK / NBK in response to apoptotic signaling by E1A and p53. Oncogene 2002; 21: 2534-44. Doi:10.1038/sj/onc/1205340.

  4. Viedma-Rodriguez R, Baiza-Gutman LA, García-Carrancá A, Moreno-Fierros L, Salamanca-Gómez F, Arenas-Aranda D. Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells. International Journal of Oncology 2013; 43(6): 1777-86. Doi:10.3892/ijo.2013.2127.

  5. Germain M, Mathai JP, Shore GC. BH-3-only BIK functions at the endoplasmic reticulum to stimulate cytochrome c release from mitochondria. The Journal of Biological Chemistry 2002; 277(20): 18053-60. Doi:10.1074/jbc.M201235200.

  6. Petros AM, Olejniczak ET, Fesik SW. Structural biology of the Bcl-2 family of proteins. Biochimica et Biophysica Acta 2004; 1644(2-3): 83-94. Doi:10.1016/j.bbamcr.2003.08.012.

  7. Breckenridge DG, Germain M, Mathai JP, Nguyen M, Shore GC. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 2003; 22(53): 8608-18. Doi:10.1038/ sj.onc.1207108.

  8. López-Muñoz E, Hernández-Zarco A, García-Hernández N, Alvarado-Cabrero I, Zarco-Espinosa G, Salamanca-Gómez F, Arenas-Aranda D. BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2012; 14(8): 586–91. Doi: 10.1007/ s12094-012-0845-8.

  9. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335(6189): 440-2. Doi:10.1038/335440a0.

  10. Klee M, Pallauf K, Alcalá S, Fleischer A, Pimentel-Muiños FX. Mitochondrial apoptosis induced by BH3-only molecules in the exclusive presence of endoplasmic reticular Bak. The EMBO Journal 2009; 28(12): 1757-68. Doi: 10.1038/ emboj.2009.90.

  11. Germain M, Mathai JP, McBride HM, Shore GC. Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis. The EMBO Journal 2005; 24(8): 1546-56. Doi:10.1038/sj.emboj.7600592.

  12. Pimentel A, Benaim G. El Ca2+ y los esfingolípidos como moduladores de la apoptosis y el cáncer. Investigación Clínica 2012; 53(1): 84-110. Retrieved from http:// scholar.google.com/scholar?hl=en&btnG=Search&q=intitle: El+Ca+y+los+esfingolípidos+como+moduladores+de+la+ apoptosis+y+el+cáncer+.#0.

  13. Hur J, Bell DW, Dean KL, Coser KR, Hilario PC, Okimoto RA, Shioda T. Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein. Cancer Research 2006; 66(20): 10153-61. Doi:10.1158/ 0008-5472.CAN-05-3696.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Hosp Jua Mex. 2014;81